Exelon

Rivastigmine Tartrate

Manufactured by Novartis Pharmaceuticals Corp., Exelon is used to treat the symptoms of mild to moderate Alzheimer’s disease.

In August 2007, the U.S. Food and Drug Administration (FDA) sent a warning letter to Novartis about safety and effectiveness claims the company made about Exelon.